Psychotropic medications in community based individuals with developmental disabilities: Observations of an interdisciplinary team

Mental Health Aspects of Developmental Disabilities

Volumn 5, Issue 3, 2002, Pages 78-86

  Howerton, Kristen ^a   Fernandez, Gail ^a   Touchette, Paul E ^a   Gurbani, Suresh ^a   Sandman, Curt A ^a   Ashurst, James ^a   Mahnovski, Natasha ^a   Downing, Arlene ^a   Lott, Ira T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressant; Antipsychotic; Bipolar; Developmental disability; Mental retardation; Psychiatric; Psychotropic medications

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CHILD; CLINICAL OBSERVATION; COMMUNITY CARE; CONSTIPATION; CONSULTATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DEFICIENCY; PATIENT COMPLIANCE; PATIENT REFERRAL; PHYSICIAN; POLYPHARMACY; PRESCRIPTION; PSYCHIATRIST; PSYCHOLOGIST; QUESTIONNAIRE; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA;

EID: 0036655237     PISSN: 10573291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Overview of pharmacotherapy: Current status and future directions
2. Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons
3. Empirical approach to psychopharmacology for institutionalized individuals with severe or profound mental retardation
4. Monitoring and evaluating psychotropic drug use for persons with mental retardation: A follow-up report
5. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability
6. Risperidone dose and blood level variability: Accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting
7. Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation
8. Drug use management in board and care facilities
9. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons
10. Changes in psychotropic drug use in long-term residents of an ICF/MR facility
11. Evaluation of an interdisciplinary review committee managing the use of psychotropic medications with people with intellectual disabilities
12. Brief report: Risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults
13. Interdisciplinary team review of psychotropic drug use in community settings
14. Reducing psychotropic drug use in an institution for the retarded
15. The use of psychopharmacological agent in a residential facility for the retarded
16. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance
17. Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study
18. A survey of prescribing psychotropic drugs in two psychiatric hospitals
19. A behavioral diagnostic paradigm for integrating behavior-analytic and psychopharmacological interventions for people with a dual diagnosis
20. Medication and programming in controlling the behavior of mentally retarded individuals in community settings
21. Psychopharmacology in developmental disabilities
22. Drug therapy for individuals with developmental disabilities: Legislation and litigation